Literature DB >> 2565769

Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system.

G B Baker1, A J Greenshaw.   

Abstract

1. A review of the effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system is presented. 2. The effects of antidepressants on adenylate cyclase activity and on receptor binding in brain tissue are discussed. Effects on a variety of receptor types are considered. 3. The utilization of electrophysiological, behavioral, and neurochemical studies to assess receptor function after chronic antidepressant administration is discussed, as is the use of peripheral receptor estimations in clinical studies. 4. Animal studies on the actions of chronic administration of neuroleptics on pre- and postsynaptic dopamine receptors are reviewed. Effects of these drugs on dopamine receptors in humans are considered from the following perspectives: postmortem and in vivo binding studies in schizophrenia, tardive dyskinesia, and central versus peripheral receptor estimation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2565769     DOI: 10.1007/BF00711441

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  240 in total

1.  Are increases in GABAB receptors consistent findings following chronic antidepressant administration?

Authors:  J A Cross; R W Horton
Journal:  Eur J Pharmacol       Date:  1987-09-02       Impact factor: 4.432

2.  Neuroleptics have identical potencies in human brain limbic and putamen regions.

Authors:  P Seeman; C Ulpian
Journal:  Eur J Pharmacol       Date:  1983-10-14       Impact factor: 4.432

3.  Specific tricyclic antidepressant binding sites in rat brain.

Authors:  R Raisman; M Briley; S Z Langer
Journal:  Nature       Date:  1979-09-13       Impact factor: 49.962

4.  The serotonin/noradrenaline-link in brain. I. The role of noradrenaline and serotonin in the regulation of density and function of beta adrenoceptors and its alteration by desipramine.

Authors:  D H Manier; D D Gillespie; E Sanders-Bush; F Sulser
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-02       Impact factor: 3.000

5.  Effect of repeated restraint stress, desmethylimipramine or adrenocorticotropin on the alpha and beta adrenergic components of the cyclic AMP response to norepinephrine in rat brain slices.

Authors:  E A Stone; J E Platt; A S Herrera; K L Kirk
Journal:  J Pharmacol Exp Ther       Date:  1986-06       Impact factor: 4.030

6.  Alpha 2-adrenergic receptor function in patients with unipolar and bipolar affective disorders.

Authors:  M S Kafka; J I Nurnberger; L Siever; S Targum; T W Uhde; E S Gershon
Journal:  J Affect Disord       Date:  1986 Mar-Apr       Impact factor: 4.839

7.  Dopamine-sensitive adenylyl cyclase in human caudate nucleus. A study in control subjects and schizophrenic patients.

Authors:  A Carenzi; J C Gillin; A Guidotti; M A Schwartz; M Trabucchi; R J Wyatt
Journal:  Arch Gen Psychiatry       Date:  1975-08

8.  Effect of various antidepressant drugs on the spontaneous firing rate of locus coeruleus and dorsal raphe neurons of the rat.

Authors:  J J Scuvée-Moreau; A E Dresse
Journal:  Eur J Pharmacol       Date:  1979-08-01       Impact factor: 4.432

9.  GABAB receptors and norepinephrine-stimulated cAMP production in rat brain cortex.

Authors:  E W Karbon; R S Duman; S J Enna
Journal:  Brain Res       Date:  1984-07-23       Impact factor: 3.252

10.  (-)-Deprenyl a selective MAO "B' inhibitor, increases [3H]imipramine binding and decreases beta-adrenergic receptor function.

Authors:  G Zsilla; M L Barbaccia; O Gandolfi; J Knoll; E Costa
Journal:  Eur J Pharmacol       Date:  1983-04-22       Impact factor: 4.432

View more
  16 in total

1.  Differential effects of chronic antidepressants in behavioural tests of beta-adrenergic and GABAB receptor function.

Authors:  D J McManus; A J Greenshaw
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Differential effects of chronic antidepressant treatment on swim stress- and fluoxetine-induced secretion of corticosterone and progesterone.

Authors:  G E Duncan; D J Knapp; S W Carson; G R Breese
Journal:  J Pharmacol Exp Ther       Date:  1998-05       Impact factor: 4.030

3.  Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications.

Authors:  L S Brady; H J Whitfield; R J Fox; P W Gold; M Herkenham
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

4.  Effects of subchronic administration of antidepressants and anxiolytics on levels of the alpha subunits of G proteins in the rat brain.

Authors:  Y Dwivedi; G N Pandey
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

5.  Chronic administration of the antidepressants phenelzine, desipramine, clomipramine, or maprotiline decreases binding to 5-hydroxytryptamine2A receptors without affecting benzodiazepine binding sites in rat brain.

Authors:  K G Todd; D J McManus; G B Baker
Journal:  Cell Mol Neurobiol       Date:  1995-06       Impact factor: 5.046

6.  Use-dependent effects of acute and chronic treatment with imipramine and buspirone on excitatory synaptic transmission in the rat hippocampus in vivo.

Authors:  J J O'Connor; M J Rowan; R Anwyl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-08       Impact factor: 3.000

7.  N2-acetylphenelzine: effects on rat brain GABA, alanine and biogenic amines.

Authors:  K F McKenna; G B Baker; R T Coutts
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-05       Impact factor: 3.000

Review 8.  Mechanism of action of St John's wort in depression : what is known?

Authors:  Veronika Butterweck
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

9.  Effects of age and of chronic antidepressant treatment on [3H]tryptamine and [3H]dihydroalprenolol binding to rat cortical membranes.

Authors:  D D Mousseau; D J McManus; G B Baker; A V Juorio; W G Dewhurst; A J Greenshaw
Journal:  Cell Mol Neurobiol       Date:  1993-02       Impact factor: 5.046

10.  Neuroadaptations to chronic exposure to drugs of abuse: relevance to depressive symptomatology seen across psychiatric diagnostic categories.

Authors:  Athina Markou; Paul J Kenny
Journal:  Neurotox Res       Date:  2002-06       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.